乳癌治療市場:現狀分析與預測(2022-2030年)

Breast Cancer Treatment Market: Current Analysis and Forecast (2022-2030)

出版日期: 2023年06月30日 | 出版商:

UnivDatos Market Insights Pvt Ltd | 英文 134 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

乳腺癌治療市場是一個競爭激烈且充滿活力的市場。該市場包括傳統療法和新興療法，如手術、化療、放療、激素療法、免疫療法和靶向療法。該市場是由乳腺癌患者數量不斷增加、技術進步以及個性化治療需求不斷增長所推動的。

預計乳腺癌治療市場在預測期內將以 9% 的複合年增長率增長。

根據治療方法，市場分為靶向治療、手術/放射治療、化療、免疫治療等。雖然靶向治療佔據市場主導地位，但免疫治療領域預計在預測期內復合年增長率最高。近年來，免疫療法因其對轉移性乳腺癌的高效療效而受到歡迎，並且在過去幾年中，多種先進的免疫療法已獲得批准。例如，2021年7月，默沙東獲得FDA批准Keytruda與化療聯合使用作為新輔助治療，並繼續單藥治療作為手術後的輔助治療，用於高危、早期三陰性乳腺癌患者。

根據癌症類型，市場分為激素受體和 HER2+。激素受體細分市場佔據市場主導地位，而 HER2+ 細分市場預計在預測期內將表現出最高的複合年增長率。HER2+ 乳腺癌患病率的增加和臨床結果的改善是 HER2+ 類別快速增長的原因。例如，根據美國癌症協會和國家癌症研究所2021年的數據，HER2+乳腺癌佔所有乳腺癌病例的14%。此外，HER2+乳腺癌藥物的不斷進步及其在聯合治療中的作用也有望提振乳腺癌市場。

根據最終用戶，市場分為醫院、門診手術中心、專科診所等。醫院作為初級保健機構預計將主導市場，而專科診所類別預計在預測期內復合年增長率最高。專科診所的優勢，如專業知識和專業護理、多學科方法、支持性護理服務的可用性以及乳腺癌相關護理的連續性，是該行業在預測期內快速增長的主要原因。此外，專科診所可以提供包括乳腺癌診斷、治療和管理在內的多種設施，這也是該行業未來快速增長的另一個原因。

為了更好地了解乳腺癌治療行業的市場採用情況，我們將市場分為北美（美國、加拿大、北美其他地區）、歐洲（德國、法國、英國、意大利、西班牙、歐洲其他地區）、亞太地區（中國、日本、印度、亞太地區其他地區）和世界其他地區根據其全球影響力進行分析。2021 年，北美在乳腺癌治療市場佔據主導地位。北美地區幾個發達國家人口中乳腺癌患病率的增加、人口老齡化、技術進步以及醫療保健支出的增加是推動市場增長的主要因素。

The breast cancer treatment market is a highly competitive and dynamic space. It includes both traditional and emerging therapies, such as surgery, chemotherapy, radiation, hormone therapy, immunotherapy, and targeted therapies. The market is driven by the growing incidence of breast cancer cases, technological advancements, and the increasing demand for personalized treatments. For instance, according to World Health Organization, in 2020, there were 2.3 million women diagnosed with breast cancer globally. As of the end of 2020, there were 7.8 million women alive who were diagnosed with breast cancer in the past 5 years, making it the world's most prevalent cancer.

Additionally, government initiatives to reduce the cost of healthcare and to provide better access to treatments are also driving the market. The market is segmented based on therapy, cancer type, end users, and geography. The key players in the market include Roche Holding AG, Novartis AG, Pfizer, Inc., Eli Lily and Company, AstraZeneca PLC, and Merck & Co., Inc.

The Breast Cancer Treatment Market is expected to grow at a strong CAGR of 9% during the forecast period.

Based on therapy, the market is segmented into targeted therapy, surgery and radiation therapy, chemotherapy, immunotherapy, and others. Targeted therapy is dominating the market while immunotherapy segment is anticipated to witness the highest CAGR during the forecast period. In recent years, Immunotherapy is gaining popularity because of its high efficacy against metastatic breast cancer and several advanced immunotherapies got approval during the past few years. For instance, in July, 2021, Merck got FDA approval for Keytruda for the treatment of patients with high-risk early-stage triple-negative breast cancer in combination with chemotherapy as neoadjuvant treatment, then continued as single agent as adjuvant treatment after surgery.

Based on cancer type, the market is segmented into Hormone Receptor and HER2+. Hormone receptor segment is dominating the market while HER2+ segment is anticipated to witness the highest CAGR during the forecast period. Increasing prevalence of HER2+ breast cancer along with improved clinical results are owing to the rapid growth of the HER2+ category. For Instance, as per the data of American Cancer Society and National Cancer Institute 2021, HER2+ breast cancer accounts for 14% of the total breast cancer cases. Moreover, continuous advancements in the HER2+ breast cancer therapeutics along with its role in combinational therapy is also expected to boost the breast cancer market.

Based on end user, the market is segmented into hospitals, ambulatory surgical centers, specialty clinics, and others. Hospital sector is expected to dominate the market as they serve as primary healthcare facility while specialty clinics category is anticipated to witness the highest CAGR during the forecast period. The benefits of specialty clinics such as expertise and specialized care, Multidisciplinary approach, availability of supportive care services, continuity of breast cancer associated care etc. are the major reasons for the rapid growth of this segment during the forecast period. Moreover, specialty clinics can provide multiple facilities including diagnostic, treatment and management of breast cancer, which is also responsible for rapid growth of this sector in future.

For a better understanding of the market adoption of the Breast Cancer Treatment industry, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, and the Rest of North America), Europe (Germany, France, U.K., Italy, Spain, Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of Asia-Pacific), Rest of World. North America dominated the Breast Cancer Treatment market in 2021. The increasing incidence of breast cancer cases among the population, the aging population, technological advancements, and increasing healthcare spending in several developed nations of North America region are the major factors driving the growth of the market.

Some of the major players operating in the market include: Novartis AG, Merck Co & Inc., Gilead, Pfizer Inc., Eli Lilly & Co., F. Hoffmann-La Roche, GlaxoSmithKline, AstraZeneca, Bristol Myers Squibb, and Seagen.

1 MARKET INTRODUCTION

1.1. Market Definitions
1.2. Main Objective
1.3. Stakeholders
1.4. Limitation

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Process of the Breast Cancer Treatment Market
2.2. Research Methodology of the Breast Cancer Treatment Market
2.3. Respondent Profile

3 MARKET SYNOPSIS

4 EXECUTIVE SUMMARY

5 IMPACT OF COVID-19 ON THE BREAST CANCER TREATMENT MARKET

6 BREAST CANCER TREATMENT MARKET REVENUE (USD Mn), 2020-2030F

7 MARKET INSIGHTS BY THERAPY

7.1. Targeted Therapy
7.2. Surgery and Radiation Therapy
7.3. Chemotherapy
7.4. Immunotherapy
7.5. Others

8 MARKET INSIGHTS BY CANCER TYPE

8.1. Hormone Receptor
8.2. HER2+

9 MARKET INSIGHTS BY END-USERS

9.1. Hospitals
9.2. Ambulatory Surgical Centers
9.3. Specialty Clinics
9.4. Others

10 MARKET INSIGHTS BY REGION

10.1. North America
- 10.1.1. U.S.
- 10.1.2. Canada
- 10.1.3. Rest of North America
10.2. Europe
- 10.2.1. Germany
- 10.2.2. France
- 10.2.3. U.K.
- 10.2.4. Italy
- 10.2.5. Spain
- 10.2.6. Rest of Europe
10.3. Asia-Pacific
- 10.3.1. China
- 10.3.2. Japan
- 10.3.3. India
- 10.3.4. Rest of APAC
10.4. Rest of the World